The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices

Sharp drop following new 20-day high

Kane Biotech Inc closed sharply lower Friday, dropping $0.01 or 12.50% to $0.04 after setting a new 20-day high. Over the last five days, shares have gained 16.67%, but are down 30.00% for the last year to date. Shares have outperformed the S&P TSX by 6.75% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.02
Updated June 24 10:41 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-1,654.20%

Although this company's net profit margin is negative, it is above the industry average and implies that Kane Biotech Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX1.69%Sector:HealthcareIndustry:Biotechnology

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit0000
Total cost of revenue0000
Total operating expense1000
Selling / general / administrative1000
Research & development0000
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total0000
Operating income-1000
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--000
Other--------
Income before tax-1000
Income after tax-1000
Income tax, total--------
Net income-1000
Total adjustments to net income--------
Net income before extra. items-1000
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1000
Inc. avail. to common incl. extra. items-1000
Diluted net income-1000
Dilution adjustment--------
Diluted weighted average shares120114108107
Diluted EPS excluding extraordinary itemsvalue per share0.000.000.000.00
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.000.000.000.00